Otogenetics Corporation is a privately-held company established in 2007. The headquarters of the company is based in Atlanta, Georgia, United States. The focus of the company is to provide products and services for the applications of the next-generation sequencing. We have received the support of NIH STTR grant, are fully GLP compliant and CLIA-certified. Otogenetics specializes in offering high coverage sequencing for panels of disease genes or pathway-focused genes (e.g., whole exome of various species, deafness genes, cancer genes, cardiomyopathy genes, etc.) and apply NGS for RNA-Seq and profiling of epigenetic modifications of genomic DNA. Otogenetics has processed thousands of exome and large-scale targeted NGS samples. We have established a reputation of uncompromised high quality for our services/products by providing a written guarantee for every project and standing by our guarantee to our customers in every project.